toxicology-congress-2017-scientifictracks-abstracts

6 / 33

Page 34
Notes:
conferenceseries.com
Volume 3, Issue 1 (Suppl) Toxicol Open Access
ISSN: 2476-2067 TYOA, an open access journal Toxicology Congress 2017
April 13-15, 2017
April 13-15, 2017 Dubai, UAE
8th World Congress on
Toxicology and Pharmacology
Phytotherapy: Transition of tradition to technology with special reference to anti-tuberculosis drugs
Sangeeta Shukla, Neelu Sinha and Amita Jaswal
Jiwaji University, India
Statement of Problem:Anti-tuberculosis drug (ATD)-induced hepatotoxicity is amajor impediment for the effective treatment
of tuberculosis (TB). All first-line anti-TB medications have adverse effects that interrupt the successful completion of TB
treatment. This study was planned to investigate the evaluation of the protective role of phytotherapy (Phyllanthus amarus
(PA) and Nigella sativa (NS) and their active principles, Phyllanthin and Thymoquinone) against liver injury caused by ATDs.
Methodology &Theoretical Orientation: Rats were treated with ATD for 8 weeks (3 days/week) as given for the treatment of
TB. This was followed by phytotherapy for 8 weeks (3 days/week).
Findings: Administration of combined ATDs induced hepatotoxicity was evident from a significant elevation in the AST, ALT,
ALP, bilirubin, albumin, cholesterol, urea, uric acid, creatinine, LPO and decreased activities of enzymes, i.e., SOD, CAT, GR,
GPX and G6PDH in liver. ATD significantly increased TNF-α, IL6, IL10 and DNA damage and showed sharp depletion in
CYP2E1 activity as assessed by estimating AH and AND activity. These altered variables were significantly reversed towards
normal after treatment with phytotherapy. Histological
studies (LM & EM) also supported biochemical findings
confirming the effectiveness of therapeutic agents.
Conclusion & Significance: Results of this study
strongly indicated protective effect of phytotherapy and
thus, can be expected as promising protective agent
in maintenance of normal hepatic function during
treatment with ATD.
Biography
Sangeeta Shukla is Vice Chancellor of Jiwaji University, Gwalior (MP) India. She has wide experience of research in the field of Biochemical Pharmacology,
Environmental Toxicology and Reproductive Biology. She has been awarded fellowship from Welcome Trust, Indo-French Government Fellowship UK and many
others. She has published 113 papers in SCI journals with good citation indices. She has also edited a book and contributed chapters in books. In recognition of
her efforts, she held international positions as Vice President for Asian Continent of International Centers for Trace Element Study for UNESCO, France including
Council Member of ISTERH. She has completed 20 major research projects and supervised 21 PhD thesis and many dissertations of MPhil and MSc students.
Sangeeta Shukla et al., Toxicol Open Access 2017, 3:1 (Suppl)